Use of a pharmaceutically active h2 relaxin in the manufacture of medicaments for treating dyspnea associated with acute heart failure and acute decompensated heart failure

摘要

The disclosure pertains to methods of reducing decompensation through acute intervention including in subjects afflicted with acute decompensated heart failure. Particularly, the disclosure provides methods for treating acute cardiac decompensation by administering a pharmaceutically effective amount of relaxin.